119例髁突骨折远期疗效的调查研究

目的：髁突骨折是临床常见病和多发病,其治疗方法目前尚存在着一定争议。本研究拟总结髁突骨折治疗方法选择的原则和适应征,旨在为髁突骨折的治疗提供更多的参考依据。方法：对四川大学华西口腔医院收治的119例治疗后6个月以上的髁突骨折患者进行远期疗效调查,以电话随访的方式作问卷调查,询问患者的张口度、语言、吞咽功能、咬合、面部容貌、并发症、对疗效的满意程度等,按照治疗方法对患者进行分类,根据患者的情况评价该组病例的治疗效果及满意度,并评价髁突骨折治疗方法的选择是否合理。结果：参与随访的119例患者中,107例对疗效满意,满意率为89．92％,50例出现明显并发症,并发症发生率为42．02％。按照治疗方法将患者分为保守治疗、内固定、髁突摘除等6类,每种治疗方法的满意率比较无统计学差异（P〉0．05）,而并发症的发生率比较有统计学差异（P〈0．05）。结论：在正确选择治疗方法的前提下,保守治疗和手术治疗髁突骨折均可取得较令人满意的疗效,但应尽量避免采用髁突摘除术。     

幼龄犬髁突囊外损伤对髁突及下颌骨生长发育的影响

目的:研究幼龄犬髁突不同形式的囊外损伤对髁突局部及下颌骨生长发育的影响。方法:20只6月龄中华田园犬随机分为五组,除空白对照组外,分别建立幼龄犬单侧髁突颈部骨折、髁突颈部骨折后内固定、髁突颈部骨膜损伤及髁突颈部骨皮质损伤四种动物模型,饲养12w及24w后通过头颅CT三维重建测量的方法观察其对下颌骨对称性及生长量的影响,并通过组织学染色观察髁突局部生长中心的微观改变。结果:1仅单侧髁突颈部骨折组在损伤早期对下颌骨及髁突发育产生了影响,使损伤侧髁突颈部形态变短变粗,下颌骨长度也较对侧减小,但髁突及颈部的局部适应性改建会逐渐抵消这些影响,24w时下颌骨已不存在骨性不对称,但功能性原因仍能导致颏点出现向患侧的偏斜。2其余三种损伤形式在实验设定的观察期内对髁突及下颌骨的生长发育影响不大,但单侧髁突颈部骨折后内固定组在24w时也出现了下颌骨的功能性偏斜。3各种损伤形式对髁突及下颌骨生长发育的远期影响有待进一步实验证实。结论:生长发育期犬髁突囊外损伤对髁突及下颌骨生长发育的影响不大。     

髁突-翼外肌解剖复位与游离复位治疗髁状突骨折的疗效比较

目的:比较髁突-翼外肌解剖复位与游离复位治疗髁状突骨折的疗效,促进髁突形态恢复。方法:收治的80例单侧髁状突骨折患者随机分为两组,每组40例,A组行髁突-翼外肌解剖复位术,B组行髁状突游离复位术,术后3个月、6个月观察髁突形态及下颌骨运动功能变化。结果:A组治愈率为90%,高于B组的70.00%(P0.05);术后3个月A组髁状突吸收、张口受限、开口偏斜、咬合关系紊乱、关节弹响发生率分别为12.50%、15.00%、15.00%、7.50%、12.50%,均低于B组的32.50%、35.00%、37.50%、25.00%、35.00%(P0.05);术后6个月A组张口受限、关节弹响发生率为5.00%、2.50%,均低于B组的20.00%、20.00%(P0.05);两组术后并发症发生率比较差异无统计学意义(P0.05)。结论:髁突-翼外肌解剖复位术保留髁状突骨折患者骨折断端血运,髁突形态及下颌骨运动能力恢复良好,疗效优于髁状突游离复位术。     

29例髁状突骨折游离再植钛板坚固内固定治疗的临床观察

目的:探讨钛板坚固内固定在髁状突骨折游离再植治疗中的作用及影响因素.方法:对29例31侧髁状突骨折游离再植坚固内固定的患者术后复诊及X线片检查临床观察,对骨折类型、固定方式、愈合和并发症状况进行分析.结果:髁状突骨折单线形19侧,多线形和碎性12侧.单板固定24侧,双板固定7侧.疗效评价总满意率83.9%;不满意率占16.1%,其中张口受限2例,髁状突移位并伴骨折缝感染吸收3例.结论:钛板坚固内固定是颌后切口入路游离再植治疗髁状突中高位及复杂性骨折满意疗效的保证,双板固定能保障髁状突多线形和碎性骨折稳定性愈合,坚持张口训练能减少术后并发症出现.     

225例髁突骨折病例的回顾性研究

目的:总结髁突骨折治疗方法选择的原则和适应征,为髁突骨折的治疗提供参考依据.方法:对225例髁突骨折住院病例进行回顾性分析,对患者的受伤年龄、性别、受伤原因、部位、合并损伤、治疗方法、疗效等方面进行分析.结果:髁突骨折多见于20-49岁男性,交通伤害的成年患者的常见病因,跌落损伤是小孩和老人患者的常见病因.骨折常发生在髁突颈,多合并颌面部其他部位骨折.高位骨折和(或)没有明显移位的骨折常采用保守治疗,中低位骨折和(或)有明显移位的骨折常采用手术治疗.结论:髁突骨折的高发人群是青壮年,最常见的致病因素为交通伤;现阶段髁突骨折的治疗方法主要有保守治疗和手术治疗,治疗方法的选择跟患者年龄、骨折部位和移位程度相关.     

口腔内入路行髁突高位骨折复位固定的临床效果

目的：探讨采用口腔内入路手术复位固定方法治疗下颌骨髁突颈骨折患者的临床效果。方法：将我院收治的20例下颌骨髁突颈骨折患者均使用口腔内入路手术复位固定方法治疗,将患者的骨折片与升支后缘骨块进行手术复位固定,并于原手术切口行回植,重建患者的下颌关节。结果：治疗后咬合关系异常者1例,开口范围限制者0例,关节疼痛者1例,均少于治疗前均为20例;治疗后关节间隙缩小者1例,髁突骨折块形状异常者1例,均少于治疗前均为20例。治疗后髁突稳定者19例,多于治疗前的1例。结论：髁突骨折治疗手术各有优缺点,采用口腔内入路手术复位固定方法治疗髁突高位骨折患者,虽然手术操作难度大,但能较好地克服了术后患者外部皮肤瘢痕明显的问题,有利于保护患者面部神经,提高患者治疗质量水平,值得临床上推广与进一步研究。     

人工单髁置换治疗膝关节骨关节炎的应用进展

人工单髁关节置换在治疗单间室骨关节炎已经有超过30年的历史,尽管早期的报告不尽如人意,但目前是可靠并安全的治疗关节炎的方法。单髁置换术的成功关键在于合适的患者的选择、细致的手术技术和避免对畸形的过度矫正。本文对人工单髁置换手术的发展历史作了简单回顾,然后分别对膝关节内、外侧单髁置换术患者的选择、手术要点、临床疗效、失败原因作一综述,并对其未来研究进行展望。     

FGFR2功能增强对小鼠下颌骨髁突发育影响

成纤维细胞生长因子受体2(Fibroblast growth factor receptor, FGFR2)是参与调控骨骼发育的重要分子,在调控软骨内成骨过程中发挥着重要作用。为了探讨FGFR2功能增强对小鼠下颌骨髁突生长发育的影响,文章以FGFR2功能增强型点突变(Fgfr2^+/S252W)小鼠为研究对象,采用番红固绿染色研究Fgfr2^+/S252W小鼠下颌骨髁突不同生长发育阶段的组织形态;利用免疫细胞化学染色和实时荧光定量PCR方法检测X型胶原(Col X)在3周龄小鼠髁突肥大软骨细胞中的表达。结果显示,1周龄、3周龄和6周龄突变型小鼠下颌骨髁突的软骨细胞层宽度都比同窝野生型窄,钙化软骨细胞层退化时间早,骨小梁钙化绿染程度深;Col X在突变型小鼠下颌骨髁突的表达高于同窝野生型小鼠(P<0.001)。结果表明,FGFR2功能增强可导致小鼠下颌骨髁突软骨层组织形态异常,抑制髁突软骨内成骨,从而导致下颌骨髁突发育畸形。     

人胚髁状突软骨细胞的改良培养及生物学特性的研究

目的:探讨行之有效的人胚髁状突软骨细胞体外分离培养方法及研究其生物学特性.方法:用0.25%胰蛋白酶和0.2%Ⅱ型胶原酶分阶段联合消化法分离髁状突软骨细胞,将分离的软骨细胞与未消化完的小片软骨共同置入预涂多聚赖氨酸的培养瓶中培养,通过倒置显微镜,免疫组织化学染色、电镜观察等方法与传统培养方法对比,检测软骨细胞的分离后存活率、贴壁生长速度及传代7次内髁状突软骨细胞表型改变相伴随的形态学及生物学特征.结果:本方法培养的人髁突软骨细胞存活率可达98%以上,细胞贴壁能力强,与传统培养方法形成细胞单层的速度相比具有统计学意义(p<0.05).7代以内培养的髁状突软骨细胞免疫组织化学染色阳性,透射电镜可见细胞内有丰富的粗面内质网及线粒体.而传统培养方法所获得的人髁状突软骨细胞存活率为90%左右,培养3代以后免疫组织化学染色显示其软骨细胞表型逐渐减弱,培养至第7代其免疫组织化学染色为阴性.结论:本方法培养的髁状突软骨细胞存活率高,且能维持软骨细胞的特有表型,至少能保持软骨细胞7代稳定,是一种简便、有效的培养方法.     

非诱导脂肪干细胞膜片复合PRF修复兔髁状突软骨缺损

目的:探索非诱导ADSCs膜片/PRF复合植入物修复兔子下颌骨髁状突软骨缺损的可行性及效果。方法:选取36只3月龄新西兰雄性大白兔,随机分为3个组即ADSCs膜片/PRF组、PRF组、空白对照组,在3%戊巴比妥钠麻醉下解剖暴露出髁状突关节面并用裂钻分别在双侧髁状突软骨面上制备一3 mm直径、3 mm深的髁突表面软骨缺损区,按实验设计每个分组分别填入相应的植入物。分别在术后4周、8周、12周处死相应时间点的动物采集髁突标本,标本进行大体及组织学检查比较。结果:术后12周时空白对照组的下颌髁状突软骨缺损未能修复,PRF组有少量不规则、不连续的软骨形成,ADSCs膜片/PRF组的修复效果较好,表面软骨接近正常纤维软骨,与周围软骨连续性较好。组织学染色也显示ADSCs膜片/PRF组优于PRF组和空白对照组。结论:证明了ADSCs膜片/PRF复合物修复髁状突软骨缺损的可行性。     

Bilan scintigraphique osseux d’une hypercondylie unilatérale

A 10-year-old girl with unilateral condylar hyperplasia was referred to our department for a bone scan. We describe the role of the bone scan in this condition. Unilateral condylar hyperplasia is a rare disease of the mandibular condyle cartilage growth leading to facial deformity. Bone scan demonstrates the active or inactive nature of condylar hyperplasia and orients therapy. A planar bone scan completed by single-photon emission computed tomography (SPECT) combined with CT was performed. Increased uptake of the left mandibular condyle, particularly well demonstrated on SPECT images, was seen. This was confirmed by relative quantification and helped decision making to surgical treatment.     

Immunolocalization of vascular endothelial growth factor in rat condylar cartilage during postnatal development

It is well known that angiogenesis is essential for the replacement of cartilage by bone during skeletal growth and regeneration. To address angiogenesis of endochondral ossification in the condyle, we examined the appearance of vascular endothelial growth factor (VEGF) and its receptor Flt-1 in condylar cartilage of the growing rat. The early expression of VEGF at various sites during condylar cartilage development indicates that VEGF plays a role in the regulation of angiogenesis at each site of bone formation. From the findings of Flt-1 immunoreactivity, the VEGF produced by the chondrocytes of the hypertrophic zone should contribute to the promotion of endothelial cell proliferation and to stimulate migration and activation of osteoclasts in condylar cartilage, resulting in the invasion of these cells into the mineralized zone.Junko Aoyama and Eiji Tanaka contributed equally to this work     

超声在糖尿病肾病诊断中的应用价值

由于快速变化的生活方式,我国糖尿病的患病率呈逐年上升趋势。糖尿病肾病(diabetic nephropathy,DN)是糖尿病最常见、最严重的微血管病变并发症之一,并且已经成为全球终末期肾病的最常见病因。因此,早期诊断、早期治疗是延缓DN进展的重点。超声是临床评价肾脏形态、功能常用的检查方法,与血、尿实验室检查相比,具有方便、快捷、无创、经济的优势。随着科学技术的发展,越来越多的超声新技术应用于临床,极大的丰富了诊断信息。本文就各项超声检查技术在检测DN患者肾脏体积、实质回声、血流动力学改变中的应用价值作一综述。得出结论:在DN早期血、尿实验室检查正常时超声已经可以发现肾脏体积、血流动力学发生了变化。因此,超声在DN的早期诊断、动态监测病程进展方面所发挥的作用是其他检查方法所不可替代的。三维超声技术和超声弹性成像在DN患者肾脏功能评价方面有着广泛研究空间及临床应用前景。     

慢性睡眠限制状态下大鼠髁突软骨MMP-1,MMP-13表达的变化

目的:探讨MMP-1,MMP-13在慢性睡眠限制引起大鼠髁突软骨结构变化中的表达变化及作用。方法:180只雄性Wistar大鼠随机分为3组(n=60):慢性睡眠限制组(CSR)、大平台组(LC)、笼养组(CON)。每组根据试验时间不同分别分为3个亚组(n=20):7天(7D)、14天(14D)、21天(21D)组。参考改良多平台法(MMPM)建立大鼠的慢性睡眠限制模型。通过HE染色观察大鼠髁突软骨的结构变化。通过免疫组化和实时定量PCR分别检测MMP-1和MMP-13的蛋白水平及m RNA水平的表达变化。结果:HE染色和扫描电镜结果显示,CSR组的大鼠髁突软骨出现了病理性的改变。与CON和LC组比较,CSR组MMP-1和MMP-13的m RNA转录和蛋白表达水平明显升高(P0.05)。结论:慢性睡眠限制能够引起大鼠颞下颌关节髁突软骨的病理性变化。MMP-1和MMP-13的表达水平的变化可能在大鼠髁突软骨病理性改变中起关键作用。     

子宫内膜异位症的临床诊断及治疗新进展

子宫内膜异位症是至今为止仍让人迷茫的疾病,现在引起人们越来越多地关注。内异症是一种进展性疾病,国内外医疗界学者试图将其早期诊断彻底治愈,但结果颇为不佳。通过临床的不断摸索,期望更全面更合理的诊断与治疗系统问世。目前其发病机制尚未彻底阐明,而在其诊断及治疗方面也缺乏特异性的方法,现就其诊断及治疗进展综述如下。     

Advances in medical decision support systems for diagnosis of acute graft-versus-host disease: molecular and computational intelligence joint approaches

Acute graft-versus-host disease (aGVHD) is a serious systemic complication of allogeneic hematopoietic stem cell transplantation (HSCT) causing considerable morbidity and mortality. Acute GVHD occurs when alloreactive donor-derived T cells recognize host-recipient antigens as foreign. These trigger a complex multiphase process that ultimately results in apoptotic injury in target organs. The early events leading to GVHD seem to occur very soon, presumably within hours from the graft infusion. Therefore, when the first signs of aGVHD clinically manifest, the disease has been ongoing for several days at the cellular level, and the inflammatory cytokine cascade is fully activated. So, it comes as no surprise that progress in treatment based on clinical diagnosis of aGVHD has been limited in the past 30 years. It is likely that a pre-emptive strategy using systemic high-dose corticosteroids as early as possible could improve the outcome of aGVHD. Due to the deleterious effects of such treatment particularly in terms of infection risk posed by systemic steroid administration in a population that is already immune-suppressed, it is critical to identify biomarker signatures for approaching this very complex task. Some research groups have begun addressing this issue through molecular and proteomic analyses, combining these approaches with computational intelligence techniques, with the specific aim of facilitating the identification of diagnostic biomarkers in aGVHD. In this review, we focus on the aGVHD scenario and on the more recent state-of-the-art. We also attempt to give an overview of the classical and novel techniques proposed as medical decision support system for the diagnosis of GVHD.     

Neurochemical approaches of cerebrospinal fluid diagnostics in neurodegenerative diseases

Alzheimer's disease (AD), Parkinson's disease dementia (PDD)/Lewy-body disease (DLB), and frontotemporal dementia (FTD) are the major causes of memory impairment and dementia. As new therapeutic agents are visible for the different diseases, there is an ultimate need for an early and an early differential diagnosis. Since cerebrospinal fluid (CSF) is in direct contact with the central nervous system (CNS), potentially promising biomarkers might be seen there first. In principle, two research approaches can be considered for the laboratory diagnosis of dementias: (i) the direct detection of disease specific protein like Abeta-peptide-oligomers in AD or alpha-synuclein-aggregates in DLB and (ii) the detection of surrogate markers that show an altered pattern of expression in early stages of the disease or are used in the differential diagnosis of other dementias and thus enable an exclusion diagnosis. Especially Abeta-peptides and tau-protein measurements seem to employ a combination of these approaches. Until now it was shown that a combined determination of just these few markers (tau-proteins and Abeta-peptides) is already sufficient to achieve a high degree of diagnostic certainty in the diagnosis of AD. However although these markers seem to correlate with neuropathological changes and memory disturbances, these markers are not specific for a single form of dementia and further research is necessary to improve especially the early differential diagnosis of dementias.     

Genetic Identification Is Critical for the Diagnosis of Parkinsonism: A Chinese Pedigree with Early Onset of Parkinsonism

Background

A number of hereditary neurological diseases display indistinguishable features at the early disease stage. Parkinsonian symptoms can be found in numerous diseases, making it difficult to get a definitive early diagnosis of primary causes for patients with onset of parkinsonism. The accurate and early diagnosis of the causes of parkinsonian patients is important for effective treatments of these patients.

Methods

We have identified a Chinese family (82 family members over four generations with 21 affected individuals) that manifested the characterized symptoms of parkinsonism and was initially diagnosed as Parkinson’s disease. We followed up with the family for two years, during which we carried out clinical observations, Positron Emission Tomography-Computed Tomography neuroimaging analysis, and exome sequencing to correctly diagnose the case.

Results

During the two-year follow-up period, we performed comprehensive medical history collection, physical examination, and structural and functional neuroimaging studies of this Chinese family. We found that the patient exhibited progressive deteriorated parkinsonism with Parkinson disease-like neuropathology and also had a good response to the initial levodopa treatment. However, exome sequencing identified a missense mutation, N279K, in exon 10 of MAPT gene, verifying that the early parkinsonian symptoms in this family are caused by the genetic mutation for hereditary frontotemporal lobar dementia.

Conclusions

For the inherited parkinsonian patients who even show the neuropathology similar to that in Parkinson’s disease and have initial response to levodopa treatment, genetic identification of the molecular basis for the disease is still required for defining the early diagnosis and correct treatment.